- Home
- DNTH vs SHCO Comparison
DNTH vs SHCO Comparison
Compare DNTH & SHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- SHCO
- Stock Information
- Founded
- DNTH 2015
- SHCO 1995
- Country
- DNTH United States
- SHCO United Kingdom
- Employees
- DNTH N/A
- SHCO N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- SHCO Hotels/Resorts
- Sector
- DNTH Health Care
- SHCO Consumer Discretionary
- Exchange
- DNTH Nasdaq
- SHCO Nasdaq
- Market Cap
- DNTH 1.0B
- SHCO 1.0B
- IPO Year
- DNTH N/A
- SHCO 2021
- Fundamental
- Price
- DNTH $37.04
- SHCO $8.86
- Analyst Decision
- DNTH Strong Buy
- SHCO Strong Buy
- Analyst Count
- DNTH 9
- SHCO 1
- Target Price
- DNTH $61.57
- SHCO $9.00
- AVG Volume (30 Days)
- DNTH 969.3K
- SHCO 2.4M
- Earning Date
- DNTH 11-06-2025
- SHCO 08-08-2025
- Dividend Yield
- DNTH N/A
- SHCO N/A
- EPS Growth
- DNTH N/A
- SHCO N/A
- EPS
- DNTH N/A
- SHCO N/A
- Revenue
- DNTH $4,854,000.00
- SHCO $1,251,591,000.00
- Revenue This Year
- DNTH N/A
- SHCO $10.81
- Revenue Next Year
- DNTH N/A
- SHCO $7.12
- P/E Ratio
- DNTH N/A
- SHCO N/A
- Revenue Growth
- DNTH 17.87
- SHCO 9.00
- 52 Week Low
- DNTH $13.37
- SHCO $4.60
- 52 Week High
- DNTH $38.59
- SHCO $8.92
- Technical
- Relative Strength Index (RSI)
- DNTH 82.86
- SHCO 75.43
- Support Level
- DNTH $36.00
- SHCO $8.81
- Resistance Level
- DNTH $24.81
- SHCO $8.88
- Average True Range (ATR)
- DNTH 2.70
- SHCO 0.03
- MACD
- DNTH 1.31
- SHCO -0.07
- Stochastic Oscillator
- DNTH 90.18
- SHCO 45.45
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About SHCO Soho House & Co Inc.
Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create, and flourish all over the world. It offers lease agreements for Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are: United Kingdom; The Americas; and Europe and Rest of the world. The majority of its revenue is generated from the Americas segment, which encompasses its operating units in the Americas, including Soho Houses, stand-alone U.S. restaurants, Soho Friends, and the management fees under a hotel management contract for the operation of The Ned London.